Bora Pharmaceutical Services Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 7333 Mississauga Rd, Mississauga, Ontario L5N 6L4, Canada (CAN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002807086 · DUNS 205556368
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-01-28
- NAIDrug Quality Assurance2019-11-07
- NAIDrug Quality Assurance2017-09-22
- NAIDrug Quality Assurance2015-07-24
- NAIDrug Quality Assurance2015-07-21
- NAIDrug Quality Assurance2013-09-25
- NAIDrug Quality Assurance2011-08-15
- VAIDrug Quality Assurance2010-07-16
- VAIDrug Quality Assurance2008-12-10
Drugs this plant is listed as making
7 distinct drugs across 16 products name this site in their FDA label.
- albendazoleAmneal Pharmaceuticals of New York LLC
- Anastrozole TabletsUpsher-Smith Laboratories, LLC
- BaclofenSlayback Pharma LLC
- Carvedilol PhosphateWaylis Therapeutics LLC
- dasatinibCycle Pharmaceuticals Ltd
- Lidocaine Hydrochloridein shortageThe J. Molner Company LLC
- tapinarofOrganon LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.